切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2013, Vol. 02 ›› Issue (05) : 238 -240. doi: 10.3877/cma.j.issn.2095-3224.2013.05.08.

所属专题: 文献

综述

miR-34a在肿瘤研究中的进展
汤庆超1, 王锡山1,()   
  1. 1. 150086 哈尔滨医科大学附属第二医院结直肠肿瘤外科 哈尔滨医科大学大肠癌研究所
  • 收稿日期:2013-07-15 出版日期:2013-10-25
  • 通信作者: 王锡山
  • Received:2013-07-15 Published:2013-10-25
引用本文:

汤庆超, 王锡山. miR-34a在肿瘤研究中的进展[J]. 中华结直肠疾病电子杂志, 2013, 02(05): 238-240.

[1]
Hermeking H.The miR-34 family in cancer and apoptosis.Cell Death Differ,2010,17(2):193-199.
[2]
Chang TC,Wentzel EA,Kent OA,et al.Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.Mol Cell,2007,26(5):745-752.
[3]
Zauli G,Voltan R,di IMG,et al.MiR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells.Clin Cancer Res,2011,17(9):2712-2724.
[4]
Bandi N,Vassella E.MiR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.Mol Cancer,2011,10:55.
[5]
Nalls D,Tang SN,Rodova M,et al.Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.PLoS One,2011,6(8):e24099.
[6]
Lal A,Thomas MP,Altschuler G,et al.Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling.PLoS Genet,2011,7(11):e1002363.
[7]
Raver-Shapira N,Marciano E,Meiri E,et al.Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.Mol Cell,2007,26(5):731-743.
[8]
Tarasov V,Jung P,Verdoodt B,et al.Differential regulation of microRNAs by p53 revealed by massively parallel sequencing:miR-34a is a p53 target that induces apoptosis and G1-arrest.Cell Cycle,2007,6(13):1586-1593.
[9]
Yamakuchi M,Ferlito M,Lowenstein CJ.MiR-34a repression of SIRT1 regulates apoptosis.Proc Natl Acad Sci U S A,2008,105(36):13421-13426.
[10]
Li N,Fu H,Tie Y,et al.MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.Cancer Lett,2009,275(1):44-53.
[11]
Weeraratne SD,Amani V,Neiss A,et al.MiR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.Neuro Oncol,2011,13(2):165-175.
[12]
Chen QR,Yu LR,Tsang P,et al.Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.J Proteome Res,2011,10(2):479-487.
[13]
Ji X,Wang Z,Geamanu A,et al.Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells.Int J Cancer,2012,131(11):2668-2677.
[14]
Wang X,Wang HK,McCoy JP,et al.Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.RNA,2009,15(4):637-647.
[15]
Hashimi ST,Fulcher JA,Chang MH,et al.MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation.Blood,2009,114(2):404-414.
[16]
Ma Y,Qin H,Cui Y.MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.Biochem Biophys Res Commun,2013,441(4):958-963.
[17]
Silber J,Jacobsen A,Ozawa T,et al.MiR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.PLoS One,2012,7(3):e33844.
[18]
Dang Y,Luo D,Rong M,et al.Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.PLoS One,2013,8(4):e61054.
[19]
Wang W,Li T,Han G,et al.Expression and role of miR-34a in bladder cancer.Indian J Biochem Biophys,2013,50(2):87-92.
[20]
Zhang J,Guo X,Shi Y,et al.Intermittent hypoxia with or without hypercapnia is associated with tumorigenesis by decreasing the expression of brain derived neurotrophic factor and miR-34a in rats.Chin Med J,2014,127(1):43-47.
[21]
Ahn YH,Gibbons DL,Chakravarti D,et al.ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.J Clin Invest,2012,122(9):3170-3183.
[22]
Li L,Xie X,Luo J,et al.Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.Mol Ther,2012,20(12):2326-2334.
[23]
Siemens H,Neumann J,Jackstadt R,et al.Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer.Clin Cancer Res,2013,19(3):710-720.
[24]
Javeri A,Ghaffarpour M,Taha MF,et al.Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis.Med Oncol,2013,30(1):413.
[25]
Schirmer U,Doberstein K,Rupp AK,et al.Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.Oncotarget,2014,5(1):463-472.
[26]
Nalls D,Tang SN,Rodova M,et al.Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.PLoS One,2011,6(8):e24099.
[27]
Hahn S,Jackstadt R,Siemens H,et al.SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.EMBO J,2013,32(23):3079-3095.
[28]
Kang J,Kim E,Kim W,et al.Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition(EMT)by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.J Biol Chem,2013,288(38):27343-27357.
[29]
Guo Y,Li S,Qu J,et al.MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells.Mol Cell Biochem,2011,354(1-2):275-282.
[30]
Liu C,Kelnar K,Liu B,et al.The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.Nat Med,2011,17(2):211-215.
[31]
de Antonellis P,Medaglia C,Cusanelli E,et al.MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.PLoS One,2011,6(9):e24584.
[32]
Jin K,Xiang Y,Tang J,et al.MiR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells.Tumour Biol,2013,35(2),1503-1510.
No related articles found!
阅读次数
全文


摘要